← Back to directory

José E. Tanus‐Santos

Researcher Next ID · RN-038029

Researcher · Biochemistry, Genetics and Molecular Biology

Universidade de Ribeirão Preto

Ribeirão Preto, Brazil

Accepting doctoral researchersFunding unknown
Works count
547
Citation count
18,004
H-index
63
i10-index
333

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Nitric Oxide and Endothelin Effects
Protease and Inhibitor Mechanisms
Renin-Angiotensin System Studies
Pregnancy and preeclampsia studies
Hormonal Regulation and Hypertension

Publications

  • Endothelial nitric oxide synthase: From biochemistry and gene structure to clinical implications of NOS3 polymorphisms

    Gene · 2015 · 10.1016/j.gene.2015.09.061

  • Hemolysis during cardiac surgery is associated with increased intravascular nitric oxide consumption and perioperative kidney and intestinal tissue damage

    Frontiers in Physiology · 2014 · 10.3389/fphys.2014.00340

  • Sodium nitrite downregulates vascular NADPH oxidase and exerts antihypertensive effects in hypertension

    Free Radical Biology and Medicine · 2011 · 10.1016/j.freeradbiomed.2011.04.005

  • Gingival crevicular fluid levels of MMP‐8, MMP‐9, TIMP‐2, and MPO decrease after periodontal therapy

    Journal Of Clinical Periodontology · 2009 · 10.1111/j.1600-051x.2009.01512.x

  • Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling

    Matrix Biology · 2009 · 10.1016/j.matbio.2009.11.005

  • Circulating Interleukin‐6 and High‐Sensitivity C‐Reactive Protein Decrease After Periodontal Therapy in Otherwise Healthy Subjects

    Journal of Periodontology · 2009 · 10.1902/jop.2009.080561

  • Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension

    Free Radical Biology and Medicine · 2009 · 10.1016/j.freeradbiomed.2009.02.011

  • Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension

    Clinical Biochemistry · 2008 · 10.1016/j.clinbiochem.2008.04.015

  • Nitric Oxide Formation Is Inversely Related to Serum Levels of Antiangiogenic Factors Soluble Fms-Like Tyrosine Kinase-1 and Soluble Endogline in Preeclampsia

    Hypertension · 2008 · 10.1161/hypertensionaha.108.115006

  • Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats

    Atherosclerosis · 2007 · 10.1016/j.atherosclerosis.2007.10.011

  • Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes

    Free Radical Biology and Medicine · 2007 · 10.1016/j.freeradbiomed.2007.06.012

  • Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma

    Clinical Biochemistry · 2006 · 10.1016/j.clinbiochem.2006.10.007

  • A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations and future needs

    Ciência & Saúde Coletiva · 2006 · 10.1590/s1413-81232006000100032

  • Susceptible and protective eNOS haplotypes in hypertensive black and white subjects

    Atherosclerosis · 2005 · 10.1016/j.atherosclerosis.2005.08.003

  • A Critical Review of Biomarkers Used for Monitoring Human Exposure to Lead: Advantages, Limitations, and Future Needs

    Environmental Health Perspectives · 2005 · https://doi.org/10.1289/ehp.7917

  • Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms

    Nitric Oxide · 2005 · 10.1016/j.niox.2005.02.002

  • Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities

    Analytical Biochemistry · 2005 · 10.1016/j.ab.2005.04.038

  • Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities

    Clinical Biochemistry · 2005 · 10.1016/j.clinbiochem.2005.02.010

  • Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men

    Pharmacogenetics and Genomics · 2005 · 10.1097/01.fpc.0000167328.85163.44

  • Biological activity of nitric oxide in the plasmatic compartment

    Proceedings of the National Academy of Sciences · 2004 · 10.1073/pnas.0402201101

  • Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease

    Nature Medicine · 2002 · https://doi.org/10.1038/nm1202-799

  • Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol

    Pharmacogenetics · 2002 · 10.1097/00008571-200207000-00008

  • Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease

    Nature Medicine · 2002 · https://doi.org/10.1038/nm799

  • Implications of Cytochrome P450 Interactions When Prescribing Medication for Hypertension

    Archives of Internal Medicine · 2002 · 10.1001/archinte.162.4.405

  • Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants

    Pharmacogenetics · 2001 · https://doi.org/10.1097/00008571-200111000-00011

Current projects

    No projects listed.